"Executive Summary: The global lennox-gastaut syndrome drug market size was valued at USD 779.89 million in 2024 and is projected to reach USD 1117.60 million by 2032, with a CAGR of 4.60% during the forecast period of 2025 to 2032  The Lennox-Gastaut Syndrome Drug Market is witnessing significant momentum driven by rising demand across diverse sectors, rapid technological advancements,...